Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis ; volume:21 ; number:1 ; day:26 ; month:7 ; year:2023 ; pages:1-12 ; date:12.2023
World journal of surgical oncology ; 21, Heft 1 (26.7.2023), 1-12, 12.2023
- Creator
-
Lai, I-Li
You, Jeng-Fu
Tsai, Wen-Sy
Hsu, Yu-Jen
Chern, Yih-Jong
Wu, Ming-Ying
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-023-03087-6
- URN
-
urn:nbn:de:101:1-2023102710073039405406
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lai, I-Li
- You, Jeng-Fu
- Tsai, Wen-Sy
- Hsu, Yu-Jen
- Chern, Yih-Jong
- Wu, Ming-Ying
- SpringerLink (Online service)
Other Objects (12)
The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Local tuning of radiomics-based model for predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Construction and Evaluation of Nomogram for Hematological Indicators to Predict Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Local tuning of radiomics-based model for predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Construction and Evaluation of Nomogram for Hematological Indicators to Predict Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Local tuning of radiomics-based model for predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Construction and Evaluation of Nomogram for Hematological Indicators to Predict Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?